ENDPOINTS

Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

Plus, news about Harmony Biosciences and Reverb Therapeutics: Genuine Biotech files for HKEX listing: The drug developer, which has multiple locations in China, joins a growing list of biotechs seeking to ...

Feb 19, 2025 - 16:09
 0
Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal
Plus, news about Harmony Biosciences and Reverb Therapeutics: Genuine Biotech files for HKEX listing: The drug developer, which has multiple locations in China, joins a growing list of biotechs seeking to ...
Read More

Tags:

Previous Article

Patient-Centered Mobile Imaging – Akumin Shows How It’s Done

Next Article

What’s next for the World Health Organization? US exit could reshape agency

Related Posts

Exelixis’ cancer drug wins approval for neuroendocrine tumors

Exelixis’ cancer drug wins approval for neuroendocrine ...

Mar 26, 2025  0

Two biotechs fail to beat or match Regeneron's Eylea in key trials

Two biotechs fail to beat or match Regeneron's Eylea in...

Mar 24, 2025  0

Cartesian reveals long-term mid-stage data for cell therapy in myasthenia gravis

Cartesian reveals long-term mid-stage data for cell the...

Apr 8, 2025  0